1. Home
  2. VKTX vs ESE Comparison

VKTX vs ESE Comparison

Compare VKTX & ESE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VKTX
  • ESE
  • Stock Information
  • Founded
  • VKTX 2012
  • ESE 1990
  • Country
  • VKTX United States
  • ESE United States
  • Employees
  • VKTX N/A
  • ESE N/A
  • Industry
  • VKTX Biotechnology: Pharmaceutical Preparations
  • ESE Telecommunications Equipment
  • Sector
  • VKTX Health Care
  • ESE Telecommunications
  • Exchange
  • VKTX Nasdaq
  • ESE Nasdaq
  • Market Cap
  • VKTX 3.4B
  • ESE 3.4B
  • IPO Year
  • VKTX 2015
  • ESE N/A
  • Fundamental
  • Price
  • VKTX $34.07
  • ESE $162.12
  • Analyst Decision
  • VKTX Strong Buy
  • ESE Strong Buy
  • Analyst Count
  • VKTX 14
  • ESE 2
  • Target Price
  • VKTX $97.29
  • ESE $147.50
  • AVG Volume (30 Days)
  • VKTX 4.8M
  • ESE 125.6K
  • Earning Date
  • VKTX 02-05-2025
  • ESE 02-06-2025
  • Dividend Yield
  • VKTX N/A
  • ESE 0.19%
  • EPS Growth
  • VKTX N/A
  • ESE 18.29
  • EPS
  • VKTX N/A
  • ESE 4.26
  • Revenue
  • VKTX N/A
  • ESE $1,055,471,000.00
  • Revenue This Year
  • VKTX N/A
  • ESE $14.05
  • Revenue Next Year
  • VKTX $986.87
  • ESE $11.19
  • P/E Ratio
  • VKTX N/A
  • ESE $40.07
  • Revenue Growth
  • VKTX N/A
  • ESE 8.94
  • 52 Week Low
  • VKTX $28.64
  • ESE $97.11
  • 52 Week High
  • VKTX $99.41
  • ESE $171.28
  • Technical
  • Relative Strength Index (RSI)
  • VKTX 51.41
  • ESE 65.15
  • Support Level
  • VKTX $28.90
  • ESE $160.23
  • Resistance Level
  • VKTX $34.37
  • ESE $167.61
  • Average True Range (ATR)
  • VKTX 2.37
  • ESE 6.00
  • MACD
  • VKTX 0.66
  • ESE 1.88
  • Stochastic Oscillator
  • VKTX 70.06
  • ESE 79.56

About VKTX Viking Therapeutics Inc.

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

About ESE ESCO Technologies Inc.

ESCO Technologies Inc sells engineered products and systems for utility, industrial, aerospace, and commercial applications. The firm operates in three segments: Aerospace and Defense, Utility Solutions Group (USG) and RF Shielding and Test (Test). The Aerospace and Defense segment designs and manufactures specialty filtration and naval products. The USG segment provides diagnostic testing solutions. The Test segment provides its customers with the ability to identify, measure and contain magnetic, electromagnetic and acoustic energy.

Share on Social Networks: